Selected research
Industry Growth & Trends
Global HER2 Antibody Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global HER2 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for HER2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for HER2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for HER2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the HER2 Antibody market include Novartis AG, Pfizer, InvivoGen, Genentech Inc, Celltrion, Bio-Techne, Biocon Limited and Abnova Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global HER2 Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The HER2 Antibody market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HER2 Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HER2 Antibody.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global HER2 Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
HER2 Antibody Market by Company
Novartis AG
Pfizer
InvivoGen
Genentech Inc
Celltrion
Bio-Techne
Biocon Limited
Abnova Corporation
HER2 Antibody Segment by Type
Ado-trastuzumab Emtansine
Lapatinib
Pertuzumab
Trastuzumab
Everolimus
HER2 Antibody Segment by Application
Hospital
Medical Center
HER2 Antibody Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HER2 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HER2 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HER2 Antibody.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of HER2 Antibody companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Ado-trastuzumab Emtansine
- Lapatinib
- Pertuzumab
- Trastuzumab
- Everolimus
Applications
- Hospital
- Medical Center
Companies covered
- Novartis AG
- Pfizer
- InvivoGen
- Genentech Inc
- Celltrion
- Bio-Techne
- Biocon Limited
- Abnova Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global HER2 Antibody Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global HER2 Antibody Market Size by Region (2021-2032)
- 1.4.1 Global HER2 Antibody Market Size by Region (2021-2026)
- 1.4.2 Global HER2 Antibody Market Size by Region (2027-2032)
- 1.5 Key Regions HER2 Antibody Market Size (2021-2032)
- 1.5.1 North America HER2 Antibody Market Size Growth Rate (2021-2032)
- 1.5.2 Europe HER2 Antibody Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific HER2 Antibody Market Size Growth Rate (2021-2032)
- 1.5.4 South America HER2 Antibody Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa HER2 Antibody Market Size Growth Rate (2021-2032)
2 HER2 Antibody Market by Type
- 2.1 Type Introduction
- 2.1.1 Ado-trastuzumab Emtansine
- 2.1.2 Lapatinib
- 2.1.3 Pertuzumab
- 2.1.4 Trastuzumab
- 2.1.5 Everolimus
- 2.2 Global HER2 Antibody Market Size by Type
- 2.2.1 Global HER2 Antibody Market Size Overview by Type (2021-2032)
- 2.2.2 Global HER2 Antibody Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global HER2 Antibody Market Size Forecasted by Type (2027-2032)
- 2.3 Global HER2 Antibody Market Size by Regions
- 2.3.1 North America HER2 Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe HER2 Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific HER2 Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America HER2 Antibody Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa HER2 Antibody Market Size Breakdown by Type (2021-2026)
3 HER2 Antibody Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Medical Center
- 3.2 Global HER2 Antibody Market Size by Application
- 3.2.1 Global HER2 Antibody Market Size Overview by Application (2021-2032)
- 3.2.2 Global HER2 Antibody Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global HER2 Antibody Market Size Forecasted by Application (2027-2032)
- 3.3 Global HER2 Antibody Market Size by Regions
- 3.3.1 North America HER2 Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe HER2 Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific HER2 Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America HER2 Antibody Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa HER2 Antibody Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 HER2 Antibody Industry Trends
- 4.2 HER2 Antibody Industry Drivers
- 4.3 HER2 Antibody Industry Opportunities and Challenges
- 4.4 HER2 Antibody Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by HER2 Antibody Revenue (2021-2026)
- 5.2 Global HER2 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global HER2 Antibody Key Company Headquarters & Area Served
- 5.4 Global HER2 Antibody Company, Product Type & Application
- 5.5 Global HER2 Antibody Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global HER2 Antibody Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 HER2 Antibody Players Market Share by Revenue in 2025
- 5.6.3 2025 HER2 Antibody Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novartis AG
- 6.1.1 Novartis AG Company Information
- 6.1.2 Novartis AG Business Overview
- 6.1.3 Novartis AG HER2 Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novartis AG HER2 Antibody Product Portfolio
- 6.1.5 Novartis AG Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer HER2 Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Pfizer HER2 Antibody Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 InvivoGen
- 6.3.1 InvivoGen Company Information
- 6.3.2 InvivoGen Business Overview
- 6.3.3 InvivoGen HER2 Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 InvivoGen HER2 Antibody Product Portfolio
- 6.3.5 InvivoGen Recent Developments
- 6.4 Genentech Inc
- 6.4.1 Genentech Inc Company Information
- 6.4.2 Genentech Inc Business Overview
- 6.4.3 Genentech Inc HER2 Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Genentech Inc HER2 Antibody Product Portfolio
- 6.4.5 Genentech Inc Recent Developments
- 6.5 Celltrion
- 6.5.1 Celltrion Company Information
- 6.5.2 Celltrion Business Overview
- 6.5.3 Celltrion HER2 Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Celltrion HER2 Antibody Product Portfolio
- 6.5.5 Celltrion Recent Developments
- 6.6 Bio-Techne
- 6.6.1 Bio-Techne Company Information
- 6.6.2 Bio-Techne Business Overview
- 6.6.3 Bio-Techne HER2 Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Bio-Techne HER2 Antibody Product Portfolio
- 6.6.5 Bio-Techne Recent Developments
- 6.7 Biocon Limited
- 6.7.1 Biocon Limited Company Information
- 6.7.2 Biocon Limited Business Overview
- 6.7.3 Biocon Limited HER2 Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Biocon Limited HER2 Antibody Product Portfolio
- 6.7.5 Biocon Limited Recent Developments
- 6.8 Abnova Corporation
- 6.8.1 Abnova Corporation Company Information
- 6.8.2 Abnova Corporation Business Overview
- 6.8.3 Abnova Corporation HER2 Antibody Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Abnova Corporation HER2 Antibody Product Portfolio
- 6.8.5 Abnova Corporation Recent Developments
7 North America
- 7.1 North America HER2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America HER2 Antibody Market Size by Country (2021-2026)
- 7.3 North America HER2 Antibody Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe HER2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe HER2 Antibody Market Size by Country (2021-2026)
- 8.3 Europe HER2 Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific HER2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific HER2 Antibody Market Size by Country (2021-2026)
- 9.3 Asia-Pacific HER2 Antibody Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America HER2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America HER2 Antibody Market Size by Country (2021-2026)
- 10.3 South America HER2 Antibody Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa HER2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa HER2 Antibody Market Size by Country (2021-2026)
- 11.3 Middle East & Africa HER2 Antibody Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst